Some researchers have even speculated that methotrexate may inhibit the expression of TNF-α, IL-6 and other pro-inflammatory cytokines released with SARS-CoV-2, thereby reducing the cytokine storm associated with COVID-19 (44, 45). This evidence concerns the gene IL6 and COVID-19.